Még nem toboroz
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
NCT07900633· 3. fázis· Eli Lilly and Company· Forrás
Contact: Patrick Morgante (principal investigator)
Toboroz
A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
NCT07816367· 3. fázis· TriGemX Bio, Inc.· Forrás
Contact: Patrick Morgante
Toboroz
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
NCT07794579· 3. fázis· Eli Lilly and Company· Forrás
Contact: Patrick Morgante (principal investigator)
Toboroz
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
NCT07684144· 3. fázis· Amgen· Forrás
Toboroz
Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and Osteoarthritis
NCT07339111· 3. fázis· Medipost, Inc.· Forrás
Contact: Millicent Clark
Toboroz
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
NCT07282600· 3. fázis· Eli Lilly and Company· Forrás
Contact: Patrick Morgante (principal investigator)
Toboroz
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
NCT06937229· 3. fázis· Bristol-Myers Squibb· Forrás
Contact: Patrick Morgante, Site 2608
Toboroz
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
NCT07231419· 3. fázis· Vertex Pharmaceuticals Incorporated· Forrás
Fut, nem toboroz
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
NCT07037433· 3. fázis· Amgen· Forrás
Toboroz
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
NCT07011745· 3. fázis· Bristol-Myers Squibb· Forrás
Contact: Patrick Morgante, Site 2608
Fut, nem toboroz
Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight
NCT06858878· 3. fázis· Amgen· Forrás
Toboroz
A Study to Assess Safety and Tolerability of PCRX-201 in Subjects With Painful Osteoarthritis of the Knee
NCT06884865· 2. fázis· Pacira Pharmaceuticals, Inc· Forrás
Contact: Millicent Clark
Fut, nem toboroz
Evaluation of the Long-term Safety and Effectiveness of Suzetrigine (SUZ) in Participants With Painful Diabetic Peripheral Neuropathy (DPN)
NCT06696443· 3. fázis· Vertex Pharmaceuticals Incorporated· Forrás
Toboroz
DermaSensor Postmarket Surveillance Study
NCT06666790· DermaSensor, Inc.· Forrás
Contact: Luke Snedaker
Toboroz
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
NCT06628908· 3. fázis· Vertex Pharmaceuticals Incorporated· Forrás
Toboroz
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
NCT06585787· 3. fázis· Karuna Therapeutics, Inc., a Bristol Myers Squibb company· Forrás
Contact: Patrick Morgante, Site 1215
Fut, nem toboroz
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)
NCT06383390· 3. fázis· Eli Lilly and Company· Forrás
Toboroz
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
NCT06112418· Cleerly, Inc.· Forrás
Contact: Ryann Sardinia
Fut, nem toboroz
ZILRETTA in Subjects With Shoulder Osteoarthritis
NCT06269705· 3. fázis· Pacira Pharmaceuticals, Inc· Forrás
Fut, nem toboroz
Safety and Pharmacodynamics of GNSC-001 Intra-articular Injection for Knee Osteoarthritis
NCT05835895· 1. fázis· Genascence Corporation· Forrás